Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

20112,005 citationsJournal Article

Authors

Good health and well-being

Published in: The Lancet

Volume 377, Issue 9767, pp. 721-731

Field-Weighted Citation Impact: 102.97